Published: 14 November 2014
Author(s): Tao Wang, Lin Liu, Yongchun Shen, Fuqiang Wen, Lei Chen
Section: Letter to the Editor

Chronic obstructive pulmonary disease (COPD), the fourth leading cause of mortality worldwide, is characterized by persistent and progressive airflow limitation, due to chronic inflammatory response in airways and lungs. In the past decade, some new non-corticosteroid drugs were applied to alleviate the inflammation in COPD, but few achieved the ideal outcomes.


Stay informed on our latest news!


This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.